Fundraising FoxAvalon BioVentures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Valora Therapeuticsvaloratherapeutics.cominJul 2024 · $30M✓ verified
Valora Therapeutics is a biotech company developing antibody-lectin chimera (AbLec) therapeutics that target cell-surface glycans for immuno-oncology and immunotherapy applications.
BiotechHealthtechLa Jolla, US
Miguel Garcia-Guzman(Co-Founder, CEO & Director)inCarolyn Bertozzi(Scientific Co-Founder)Jessica Stark(Scientific Co-Founder)inJames Lee(VP, Business Development)in
BoardStefan Heller(Director)Sanford Madigan(Director)in
Co-investorsCorrelation VenturesAlexandria
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.